MAPK3 and hepatocellular carcinoma: They identified 1918 phosphorylation sites from 1033 phosphoproteins and also found novel phosphorylation sites related to progression of HCC such as pT185 for ERK2 and pY204 for ERK1 that were down regulated in HCC [33].